← Latest Filings

V

Venker Eric

President & Immunovant CEO

Open-market buys

0

$0 total

Open-market sells

27

$101.2M total

Tracking since

Oct 2025

Activity timeline

Open-market sale — $7.3M

Roivant Sciences Ltd. · Oct 28, 2026

Open-market sale — $501K

Roivant Sciences Ltd. · Oct 20, 2026

Open-market trades from the last two years.

Holdings as last reported

3,644,834 Stock Option (Right to Buy) in ROIV

Held directly · as of 2026-09-30

1,199,154 Common Shares in ROIV

Held directly · as of 2026-10-28

Companies touched

Roivant Sciences Ltd.

Immunovant, Inc.